The surgical management of insulinoma is frequently complicated by difficulty in pre-and intra-operative localization of the tumour. An early and reliable post-operative indicator of successful surgery would therefore be useful in the management of this condition.
Introduction
Surgical removal of insulinoma abolishes symptoms of neuroglycopenia and is therefore the treatment ofchoice for this condition.' Post-operatively serum insulin concentrations fall to normal2 although high post-operative values occasionally have been reported. 3 It is unclear whether the latter results are observed following successful removal of the tumour or arise as a consequence of the well recognized difficulties of identifying small tumours with certainty.4 A reliable, early post-operative indicator of successful surgery would therefore be useful in the surgical management of insulinoma.
The aim of this controlled study was to determine whether serial intra-operative measurements of blood glucose and serum insulin concentrations would provide corroborative retrospective evidence that removal of the tumour had been successfully accomplished in patients with insulinoma.
Patients and methods
Five patients presenting with neurological symptoms were diagnosed as having an insulinoma following the demonstration of fasting hypoglycaemia in the presence of an inappropriate elevation of serum insulin concentration. Four of the patients underwent partial distal pancreatectomy and local excision ofthe tumour was carried out in the remaining patient. Surgery resulted in the complete abolition of neuroglycopenic symptoms in all the patients during follow-up periods of between 1.5 
Results
Following induction of anaesthesia blood glucose concentration was normal in both insulinoma patients and controls at 6.4 ± 0.8 vs 5.6 ± 0.3 mmol/l ( Figure 1 ). Blood glucose rose significantly in the insulinoma patients following removal of the tumour to 9.7 + 0.9 mmol/l (P< 0.05) but was unchanged in the control group (6.9 ± 0.5 mmol/l; Figure 1 ) Serum insulin at the start of surgery was significantly elevated in the insulinoma patients at 32.1 ± 3.1 vs 6.1 ± 2.2 mU/I (P< 0.01; Figure 2 ) and fell significantly following removal of the tumour to 7.5 + 1.8 mU/l (P< 0.01; Figure 2 ---------- 1- group.bmj.com on August 15, 2017 -Published by http://pmj.bmj.com/ Downloaded from insulin concentration following the removal of insulinomas.""2 We have confirmed that tumour removal is followed by a significant rise in blood glucose concentration in insulinoma patients. However, the reliability of blood glucose as a marker of successful surgery has been questioned since similar rises in blood glucose have been observed in patients subsequently documented to have retained tumour or multiple adenomatosis. '2 In addition to the rise in blood glucose a significant fall in serum insulin concentration was observed after excision of the insulinomas. Following removal of the tumours serum insulin concentrations in the insulinoma patients fell to levels comparable to the control group. Endogenously secreted insulin has a half-life of less than 5 minutes in the circulation'4"15 though a significant proportion of the circulating radio-immunoassayable insulin in insulinoma patients is proinsulin which has a plasma half-life of about 25 minutes. [15] [16] [17] We consider that the prompt fall in serum insulin concentration provides convincing corroborative evidence of successful tumour removal in our patients.
Body weight,'8 counter-regulatory hormone responses to surgery'3 and intravenous glucose infusion may all affect circulating glucose and insulin concentrations. To examine these factors a control group of patients undergoing abdominal surgery was studied under identical conditions. No significant changes in blood glucose or serum insulin concentration were observed in this group during the operative period. While we acknowledge the limitations of our control group, patients with any other condition necessitating partial pancreatectomy would clearly have been unsuitable as controls due to their inherent pancreatic disease. It is therefore not possible to perform a valid assessment of the effect of an acute 50% reduction in pancreatic volume on circulating glucose and insulin concentrations in man. We consider that such a marked fall in circulating insulin concentrations would be highly unlikely if an insulin-secreting tumour had been missed during partial pancreatectomy and it is of note that the changes in glucose and insulin concentrations observed in the patient who underwent local tumour excision were indistinguishable from those of the patients who underwent partial pancreatectomy. None of the patients has had a recurrence of neuroglycopenic symptoms during up to 3 years of post-operative follow-up. A larger prospective study will be required to determine the relative false positive and false negative rates of this technique. However, the marked fall in serum insulin in all our patients suggests that in an individual case failure to remove the functioning tumour tissue would be readily apparent.
In summary, we conclude that serial measurements of blood glucose and serum insulin concentrations during surgery are technically simple to perform and provide useful retrospective corroboration ofsuccessful surgery in patients with insulinoma.
